backgroundsl
back
back-nod
back5
back

Our successful development is best represented by the following

  • Coverage of 27 countries
  • 570 + million population access
  • 22 years experience
  • 227 completed Clinical Trials *
  • 168 Quality of Life projects *
  • 8 105 Patients enrolled in clinical trials *
  • 11 214 Study Investigators
  • 342 Audits/ Inspections/ Co-monitoring visits *
  • 360 Certificates of quality/ Attendance/ Recognition and Training
  • FDA inspected sites, NAI Letters issued
  • FDA Pre-IND Meetings
  • EU RA Scientific Advice Meetings

*For the last 3 years

Recognition

  • Certificate of Recognition by USA NIH (2002)
  • FDA inspected Sites
  • EMA inspected Sites
  • PMDA inspected Sites
  • FDA pre-IND Meetings
  • EU Scientific Advice Meetings on drug development programs with EU Competent Authorities
  • 24-bed (incl. 6 intensive care) Early Phase Clinical Research Center (since 2005), Certified by the Ministry of Research and Science of France
  • ISO 9001:2015 Certified and Re-certified (since 2004)
  • CDISC Partner
  • DIA Partner
  • Academia Partner
  • PSCI Principles Compliant
  • HORIZON 2020 Beneficiary
  • Milen Vrabevski, MD (Owner/CEO) – Member of Clinton Global Initiative (2012)
  • Milen Vrabevski, MD (Owner/CEO) – European Citizens’ Prize laureate (2013)
  • PYTHAGORAS Reward Laureate, granted for contribution to science by the Ministry of Education & Science (2016)

Comac Medical Reach

map comac

Coverage:

Bulgaria (Sofia HQ) Germany Bosnia and Herzegovina Latvia Lithuania Estonia
Georgia Macedonia Romania Serbia Moldova Montenegro
Slovenia Poland Hungary Albania Kosovo Cyprus
Greece Croatia Kazakhstan United Kingdom Czech Republic Turkey
USA
© Copyright - Comac Medical Ltd.